日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Covalent Alkynylpyridopyrimidinones Targeting Cysteine 775 of the Epidermal Growth Factor Receptor Overcome Resistance to Current Therapies

共价炔基吡啶并嘧啶酮靶向表皮生长因子受体的半胱氨酸775,克服对现有疗法的耐药性

Hannah L Stewart,Cinzia Bordoni,Claire E Jennings,Islam Al-Khawaldeh,Mathew P Martin,Richard A Noble,Nicole Phillips,Sara Pintar,Lisa Prendergast,Huw D Thomas,Lan-Z Wang,Jessica E Watt,Anita Wittner,Agnieszka K Bronowska,Céline Cano,Martin E M Noble,Stephen R Wedge,Michael J Waring

Fragment expansion with NUDELs - poised DNA-encoded libraries

使用 NUDEL 进行片段扩展 - 准备就绪的 DNA 编码文库

Catherine L A Salvini, Benoit Darlot, Jack Davison, Mathew P Martin, Susan J Tudhope, Shannon Turberville, Akane Kawamura, Martin E M Noble, Stephen R Wedge, James J Crawford, Michael J Waring

Targeting Cytotoxic Agents through EGFR-Mediated Covalent Binding and Release

通过 EGFR 介导的共价结合和释放靶向细胞毒药物

Pasquale A Morese, Nahoum Anthony, Michael Bodnarchuk, Claire Jennings, Mathew P Martin, Richard A Noble, Nicole Phillips, Huw D Thomas, Lan Z Wang, Andrew Lister, Martin E M Noble, Richard A Ward, Stephen R Wedge, Hannah L Stewart, Michael J Waring

Comparison of Quantitative Mass Spectrometric Methods for Drug Target Identification by Thermal Proteome Profiling

通过热蛋白质组分析进行药物靶标鉴定的定量质谱方法比较

Amy L George, Frances R Sidgwick, Jessica E Watt, Mathew P Martin, Matthias Trost, José Luis Marín-Rubio, Maria Emilia Dueñas

Parallel Optimization of Potency and Pharmacokinetics Leading to the Discovery of a Pyrrole Carboxamide ERK5 Kinase Domain Inhibitor

药效和药代动力学的并行优化导致发现吡咯酰胺 ERK5 激酶结构域抑制剂

Duncan C Miller, Tristan Reuillon, Lauren Molyneux, Timothy Blackburn, Simon J Cook, Noel Edwards, Jane A Endicott, Bernard T Golding, Roger J Griffin, Ian Hardcastle, Suzannah J Harnor, Amy Heptinstall, Pamela Lochhead, Mathew P Martin, Nick C Martin, Stephanie Myers, David R Newell, Richard A Nobl

A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia

基质辅助激光解吸/电离飞行时间分析证实尼洛替尼是急性髓系白血病炎症抑制剂

José Luis Marín-Rubio, Rachel E Peltier-Heap, Maria Emilia Dueñas, Tiaan Heunis, Abeer Dannoura, Joseph Inns, Jonathan Scott, A John Simpson, Helen J Blair, Olaf Heidenreich, James M Allan, Jessica E Watt, Mathew P Martin, Barbara Saxty, Matthias Trost

Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition

CDK1 和 CDK2 构象能量景观的差异提示了实现选择性 CDK 抑制的机制

Daniel J Wood, Svitlana Korolchuk, Natalie J Tatum, Lan-Zhen Wang, Jane A Endicott, Martin E M Noble, Mathew P Martin

Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor

CCT068127 的分子分析和组合活性:一种有效的 CDK2 和 CDK9 抑制剂

Steven R Whittaker, Clare Barlow, Mathew P Martin, Caterina Mancusi, Steve Wagner, Annette Self, Elaine Barrie, Robert Te Poele, Swee Sharp, Nathan Brown, Stuart Wilson, Wayne Jackson, Peter M Fischer, Paul A Clarke, Michael I Walton, Edward McDonald, Julian Blagg, Martin Noble, Michelle D Garrett, 

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines

细胞周期蛋白依赖性激酶 (CDK) 抑制剂:结构-活性关系以及对 6-取代 2-芳氨基嘌呤的 CDK-2 选择性的见解

Christopher R Coxon, Elizabeth Anscombe, Suzannah J Harnor, Mathew P Martin, Benoit Carbain, Bernard T Golding, Ian R Hardcastle, Lisa K Harlow, Svitlana Korolchuk, Christopher J Matheson, David R Newell, Martin E M Noble, Mangaleswaran Sivaprakasam, Susan J Tudhope, David M Turner, Lan Z Wang, Step

Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule Inhibitors

小分子激酶功能的结构基础以及被各种小分子抑制剂抑制的作用

Jin-Yi Zhu, Rebecca A Cuellar, Norbert Berndt, Hee Eun Lee, Sanne H Olesen, Mathew P Martin, Jeffrey T Jensen, Gunda I Georg, Ernst Schönbrunn